Literature suggested that impairment of IGF1 synthesis results in a worsening state of insulin resistance138, and reduced IGF1 expression caused fibrosis139, suggesting igf1 could have enhanced NASH pathogenesis in the liver of BPA lineage females, a master regulator. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatohepatitis.